NCT03462017 - Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

December 22, 2018

Study Completion Date

December 22, 2018

Conditions

Microvascular Coronary Artery Disease

Interventions

DRUG

SAR247799

Pharmaceutical form:Capsule Route of administration: Oral

DRUG

Placebo

Pharmaceutical form:Capsule Route of administration: Oral

DRUG

Sildenafil

Pharmaceutical form:Encapsulated tablet Route of administration: Oral

DRUG

Acetylcholine

Pharmaceutical form:Solution Route of administration: Transdermal

Trial Locations (2)

Investigational Site Number 2760001, Neuss

Investigational Site Number 2760002, Mainz